Yano K, Toki S, Nakanishi S, Ochiai K, Ando K, Yoshida M, Matsuda Y, Yamasaki M
Tokyo Research Laboratories, Kyowa Hakko Kogyo Co. Ltd, Japan.
Bioorg Med Chem. 1996 Jan;4(1):115-20. doi: 10.1016/0968-0896(95)00175-1.
A novel cyclic peptide, MS-271, was isolated from the culture broth of an actinomycete, Streptomyces sp. M-271 as an inhibitor of smooth muscle myosin light chain kinase (MLCK). MS-271 inhibited the MLCK from chicken gizzard with an IC50 value of 8 microM. MS-271 did not inhibit cyclic AMP-dependent protein kinase, protein kinase C or calcium/calmodulin-dependent cyclic nucleotide phosphodiesterase at concentrations up to 400 microM. The primary structure of MS-271 was identical to that of siamycin I, an anti-HIV peptide isolated from a microbial source.
从链霉菌属(Streptomyces sp.)M-271的放线菌培养液中分离出一种新型环肽MS-271,它是平滑肌肌球蛋白轻链激酶(MLCK)的抑制剂。MS-271抑制鸡肫MLCK的IC50值为8微摩尔。在浓度高达400微摩尔时,MS-271不抑制环磷酸腺苷依赖性蛋白激酶、蛋白激酶C或钙/钙调蛋白依赖性环核苷酸磷酸二酯酶。MS-271的一级结构与从微生物来源分离出的抗HIV肽西阿霉素I相同。